Du et al. reported that radiotherapy upregulated PD-L1 expression in HCC by activating the intrinsic cGAS-STING pathway, leading to immune evasion; therefore, combination therapy with anti-PD-L1 blockade potentiated the antitumor effect of radiotherapy [82]. This evidence concerns the gene STING1 and hepatocellular carcinoma.